新生儿维生素D的决定因素与测量:使用CLIA检测技术对脐血25(OH)D的高估
本研究为维生素D产前哮喘减少试验(VDAART)的辅助分析,纳入881名高危孕妇,比较CLIA与LC-MS/MS检测脐血25(OH)D,发现CLIA测量值(均值37.13 ng/mL)高于LC-MS/MS(均值23.54 ng/mL),平均正偏倚13.54 ng/mL,而母体样本无此偏倚;孕晚期而非孕早期母体25(OH)D是新生儿25(OH)D的决定因素之一。
要点
- CLIA检测脐血25(OH)D较LC-MS/MS平均高估13.54 ng/mL,母体样本无此偏倚。
- 孕晚期母体25(OH)D是新生儿25(OH)D的决定因素之一,孕早期则不是。
- CLIA不应用于脐血样本的25(OH)D定量检测。
核心结论
- 化学发光免疫分析法(CLIA)高估人脐血样本中的25(OH)D水平,此效应在母体血样本中未观察到。
- CLIA检测脐血样本的25(OH)D定量不应被视为有效。
- 孕晚期而非孕早期母体25(OH)D是新生儿25(OH)D状态的若干决定因素之一。
研究设计与样本
- 本研究为维生素D产前哮喘减少试验(VDAART)的辅助分析,该试验为随机、双盲、安慰剂对照研究。
- 共881名高哮喘风险子代孕妇被随机分配接受维生素D补充或安慰剂。
- 采集孕早期和孕晚期母体血清及出生时子代脐血样本。
- 所有母体和子代样本用CLIA检测25(OH)D,所有子代样本及200份孕晚期母体子集样本用LC-MS/MS检测。
主要发现
- 脐血25(OH)D水平CLIA测量均值37.13 ng/mL(SD 18.30),LC-MS/MS测量均值23.54 ng/mL(SD 11.99)。
- Bland-Altman分析显示CLIA平均正偏倚13.54 ng/mL(SD 12.92)。
- CLIA检测的正偏倚在母体样本中未观察到。
- 孕晚期25(OH)D是新生儿25(OH)D水平的正向决定因素。
临床怎么用
- 作者认为CLIA检测脐血样本的25(OH)D定量不应被视为有效。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Vitamin D (VD) deficiency in pregnancy and the neonatal period has impacts on childhood outcomes. Maternal VD sufficiency is crucial for sufficiency in the neonate, though the effect of early versus late pregnancy 25-hydroxy-vitamin D (25(OH)D) levels on neonatal levels is unknown. Furthermore, chemiluminescence immunoassays (CLIAs) are widely used, though their validity in measuring 25(OH)D specifically in cord blood specimens has not been established. OBJECTIVE: To assess the validity of a CLIA in the measurement of cord blood 25(OH)D and to evaluate maternal determinants of neonatal 25(OH)D, including early versus late pregnancy 25(OH)D levels. DESIGN: This is an ancillary analysis from the Vitamin D Antenatal Asthma Reduction Trial (VDAART), a randomized, double-blinded, placebo-controlled study. PARTICIPANTS AND INTERVENTION: A total of 881 pregnant women at high risk of having offspring asthma were randomized to receive VD supplementation or placebo. Serum samples were collected from mothers in early and late pregnancy and from offspring cord blood at birth. 25(OH)D levels were assayed by CLIA in all maternal and offspring samples and by LC-MS/MS in all offspring samples and a subset of 200 maternal third trimester samples. RESULTS: Cord blood 25(OH)D levels were higher as measured by CLIA (mean 37.13 ng/mL [SD 18.30]) than by LC-MS/MS (mean 23.54 ng/mL [SD 11.99]), with a mean positive bias of 13.54 ng/mL (SD 12.92) by Bland-Altman analysis. This positive bias in measurement by CLIA was not observed in maternal samples. Third trimester 25(OH)D was a positive determinant of neonatal 25(OH)D levels. CONCLUSION: Chemiluminescence immunoassays overestimate 25(OH)D levels in human cord blood samples, an effect not observed in maternal blood samples. The quantification of 25(OH)D by CLIA should therefore not be considered valid when assayed in cord blood samples. Third trimester, but not first trimester, maternal 25(OH)D is one of several determinants of neonatal 25(OH)D status.
引用
- Lu M, Hollis BW, Carey VJ, et al. Determinants and Measurement of Neonatal Vitamin D: Overestimation of 25(OH)D in Cord Blood Using CLIA Assay Technology. J Clin Endocrinol Metab. 2020. PMID: 31872219. doi:10.1210/clinem/dgz299
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。